The first implants of the Israeli startup CorNeat Vision’s synthetic cornea, which bio-integrates with the host’s eye, has received approval to conduct clinical trials on patients at Beilinson Hospital in central Israel.
By ILH Staff
The Israeli startup CorNeat Vision has received approval to conduct clinical trials of a synthetic cornea that bio-integrates with the human eye.
The Health Ministry-approved trial of the CorNeat KPro will be run at Beilinson Hospital in Petach Tikva on 10 patients suffering from corneal blindness who are either not candidates for or have experienced one or more failed cornea transplants, the company announced last week. Continue Reading »